Form D · Private Equity Fund

NovaQuest Pharma Opportunities Fund IV, L.P.

Raleigh, NC · CIK 0001644216

Offering snapshot reported Jun 11, 2015 · SEC filing

Reported sold: Yet to sell
Investors reported: 0
Minimum accepted: $0
First sale: Yet to occur

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 11, 2015	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-241580

Amount to be paid is generally based on a percentage of limited partner subscriptions.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Atlantic-Pacific Capital, Inc.	38356

Source: Form D, filed Jun 11, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

NOVAQUEST PHARMA OPPORTUNITIES FUND IV, L.P.

Investment adviser: NOVAQUEST CAPITAL MANAGEMENT, L.L.C.

Gross asset value: $126M
Beneficial owners: 37
ADV minimum commitment: $25M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator PINNACLE FUND SERVICES, LTD VANCOUVER, Canada Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor BDO CAYMAN LTD. GRAND CAYMAN, Cayman Islands

Custodian SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK SANTA CLARA, California, United States Related to adviser: No

Custodian WELLS FARGO BANK, N.A. SAN FRANCISCO, California, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

BDO CAYMAN LTD.
PCAOB 2162

SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35

WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09

Filing source

Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-7328857121

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
NovaQuest Pharma Opportunities Fund III, L.P.	Nov 14, 2012	$426,099,500	8
NovaQuest Pharma Opportunities Fund IV, L.P. (this fund)	Jun 11, 2015	Yet to sell	0
NovaQuest Pharma Opportunities Fund V, L.P.	Jun 21, 2019	$892,750,000	13
NovaQuest Pharma Opportunities Fund VI, L.P.	Jun 12, 2024	$90,000,000	2

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
John L. Bradley	Director
Ernest Gerald Brown	Director
Hisaharo Koga	Director
N/A Nq Pof Iv Gp, L.P.	Executive
N/A Nq Pof Iv Gp, Ltd.	Executive
Ronald Wooten	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

4208 Six Forks Road, Suite 920
Raleigh, NC, 27609